Google is contemplating charging for its AI-powered search features, the FDA has approved Prenosis' AI tool for diagnosing sepsis, the U.S. and EU are set to announce a collaboration on AI oversight, and OpenAI has restructured its corporate venture fund, removing CEO Sam Altman as the owner and manager.